Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Wong, Ryan Y ^a   Oxendine, Sarah E ^a   Godwin, John ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Anxiety; Brain; Fluoxetine; GABA; Genomic; RNA sequencing; Serotonin; SSRI; Stress; Zebrafish

Indexed keywords

AMINO ACID; FLUOXETINE; ISOTOCIN; LIPID; NEUROPEPTIDE Y; PROLACTIN; RNA; STEROID; TRANSCRIPTOME; UROCORTIN III;

AMINO ACID METABOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENOMICS; LIPID METABOLISM; MALE; NEUROGENOMICS; NONHUMAN; PROTEIN EXPRESSION; RACEMIC MIXTURE; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; STEREOISOMERISM; STEROIDOGENESIS; STRESS; TRANSCRIPTOMICS; TREATMENT DURATION; WILD SPECIES; ZEBRA FISH;

ANIMALIA; DANIO RERIO;

EID: 84878009771     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-348     Document Type: Article

References (128)

1. American Psychiatric Association Diagnostic criteria from DSM-IV-TR 2000, Washington, D.C: American Psychiatric Association, American Psychiatric Association.
2. Cryan JF, Sweeney FF. The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol 2011, 164:1129-1161. 10.1111/j.1476-5381.2011.01362.x, 3229755, 21545412.
3. Durant C, Christmas D, Nutt D. The pharmacology of anxiety. Curr Top Behav Neurosci 2010, 2:303-330.
4. Jacobson LH, Cryan JF. Genetic approaches to modeling anxiety in animals. Curr Top Behav Neurosci 2010, 2:161-201.
5. Westenberg HG. Recent advances in understanding and treating social anxiety disorder. CNS Spectr 2009, 14:24-33.
6. Pinna G, Costa E, Guidotti A. Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids. Proc Natl Acad Sci USA 2004, 101:6222-6225. 10.1073/pnas.0401479101, 395950, 15069199.
7. Wong DT, Bymaster FP, Engleman EA. Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci 1995, 57:411-441. 10.1016/0024-3205(95)00209-O, 7623609.
8. Wong DT, Bymaster FP, Reid LR, Fuller RW, Perry KW. Inhibition of serotonin uptake by optical isomers of fluoxetine. Drug Dev Res 1985, 6:397-403.
9. Koch S, Perry KW, Nelson DL, Conway RG, Threlkeld PG, Bymaster FP. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology 2002, 27:949-959. 10.1016/S0893-133X(02)00377-9, 12464452.
10. Robertson DW, Krushinski JH, Fuller RW, Leander JD. Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor. J Med Chem 1988, 31:1412-1417. 10.1021/jm00402a027, 3260286.
11. Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF, Elkhayat SI, Bartels BK, Tien AK, Tien DH. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009, 205:38-44. 10.1016/j.bbr.2009.06.022, 2922906, 19540270.
12. Dulawa SC, Holick KA, Gundersen B, Hen R. Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression. Neuropsychopharmacology 2004, 29:1321-1330. 10.1038/sj.npp.1300433, 15085085.
13. Pinna G, Costa E, Guidotti A. SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol 2009, 9:24-30. 10.1016/j.coph.2008.12.006, 2670606, 19157982.
14. Pinna G, Costa E, Guidotti A. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl) 2006, 186:362-372.
15. Longone P, Di Michele F, D'Agati E, Romeo E, Pasini A, Rupprecht R. Neurosteroids as neuromodulators in the treatment of anxiety disorders. Front Endocrinol (Lausanne) 2011, 2:55.
16. Barbaccia ML. Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs. Crit Rev Neurobiol 2004, 16:67-74. 10.1615/CritRevNeurobiol.v16.i12.70, 15581401.
17. Reddy DS, O'Malley BW, Rogawski MA. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 2005, 48:14-24. 10.1016/j.neuropharm.2004.09.002, 15617723.
18. Pinna G, Rasmusson AM. Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder. J Neuroendocrinol 2012, 24:102-116. 10.1111/j.1365-2826.2011.02234.x, 3245370, 21981145.
19. Schule C, Eser D, Baghai TC, Nothdurfter C, Kessler JS, Rupprecht R. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?. Neuroscience 2011, 191:55-77.
20. Guidotti A, Dong E, Matsumoto K, Pinna G, Rasmusson AM, Costa E. The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5α-dihydroprogesterone in psychiatric disorders. Brain Res Rev 2001, 37:110-115. 10.1016/S0165-0173(01)00129-1, 11744079.
21. Pinna G, Dong E, Matsumoto K, Costa E, Guidotti A. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci USA 2003, 100:2035-2040. 10.1073/pnas.0337642100, 149954, 12571361.
22. Jain NS, Hirani K, Chopde CT. Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats. Neuropharmacology 2005, 48:627-638. 10.1016/j.neuropharm.2004.11.016, 15814098.
23. Bitran D, Foley M, Audette D, Leslie N, Frye CA. Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl) 2000, 151:64-71.
24. Landgraf R. Neuropeptides in anxiety modulation. Handb Exp Pharmacol 2005, 169:335-369. 10.1007/3-540-28082-0_12, 16594264.
25. Semsar K, Perreault HA, Godwin J. Fluoxetine-treated male wrasses exhibit low AVT expression. Brain Res 2004, 1029:141-147. 10.1016/j.brainres.2004.09.030, 15542067.
26. Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005, 4:775-790. 10.1038/nrd1825, 16138108.
27. Overli O, Pottinger TG, Carrick TR, Overli E, Winberg S. Differences in behaviour between rainbow trout selected for high- and low-stress responsiveness. J Exp Biol 2002, 205:391-395.
28. Landgraf R, Wigger A. High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav Genet 2002, 32:301-314. 10.1023/A:1020258104318, 12405513.
29. Wong RY, Perrin F, Oxendine SE, Kezios ZD, Sawyer S, Zhou L, Dereje S, Godwin J. Comparing behavioral responses across multiple assays of stress and anxiety in zebrafish (Danio rerio). Behaviour 2012, 149:1205-1240.
30. Maximino C, de Brito TM, da Silva Batista AW, Herculano AM, Morato S, Gouveia A. Measuring anxiety in zebrafish: a critical review. Behav Brain Res 2010, 214:157-171. 10.1016/j.bbr.2010.05.031, 20510300.
31. Stewart A, Gaikwad S, Kyzar E, Green J, Roth A, Kalueff AV. Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology 2012, 62:135-143. 10.1016/j.neuropharm.2011.07.037, 3195883, 21843537.
32. Clark KJ, Boczek NJ, Ekker SC. Stressing zebrafish for behavioral genetics. Rev Neurosci 2011, 22:49-62. 3470424, 21615261.
33. Steenbergen PJ, Richardson MK, Champagne DL. The use of the zebrafish model in stress research. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1432-1451. 10.1016/j.pnpbp.2010.10.010, 20971150.
34. Champagne DL, Hoefnagels CC, de Kloet RE, Richardson MK. Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav Brain Res 2010, 214:332-342. 10.1016/j.bbr.2010.06.001, 20540966.
35. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013, 496:498-503. 10.1038/nature12111, 23594743.
36. Griebel G, Belzung C, Perrault G, Sanger DJ. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 2000, 148:164-170.
37. Miller BH, Schultz LE, Gulati A, Su AI, Pletcher MT. Phenotypic Characterization of a Genetically Diverse Panel of Mice for Behavioral Despair and Anxiety. PLoS One 2010, 5:e14458. 10.1371/journal.pone.0014458, 3012073, 21206921.
38. Panula P, Chen YC, Priyadarshini M, Kudo H, Semenova S, Sundvik M, Sallinen V. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 2010, 40:46-57. 10.1016/j.nbd.2010.05.010, 20472064.
39. Lillesaar C. The serotonergic system in fish. J Chem Neuroanat 2011, 41:294-308. 10.1016/j.jchemneu.2011.05.009, 21635948.
40. Wang Y, Takai R, Yoshioka H, Shirabe K. Characterization and expression of serotonin transporter genes in zebrafish. Tohoku J Exp Med 2006, 208:267-274. 10.1620/tjem.208.267, 16498236.
41. Gould GG, Brooks BW. Frazer A: [(3)H] citalopram binding to serotonin transporter sites in minnow brains. Basic Clin Pharmacol Toxicol 2007, 101:203-210. 10.1111/j.1742-7843.2007.00100.x, 17697042.
42. Park JW, Heah TP, Gouffon JS, Henry TB, Sayler GS. Global gene expression in larval zebrafish (Danio rerio) exposed to selective serotonin reuptake inhibitors (fluoxetine and sertraline) reveals unique expression profiles and potential biomarkers of exposure. Environ Pollut 2012, 167:163-170.
43. Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005, 4:35-44. 10.1038/nrd1606, 15688071.
44. Rihel J, Schier AF. Behavioral screening for neuroactive drugs in zebrafish. Dev Neurobiol 2012, 72:373-385. 10.1002/dneu.20910, 21567979.
45. Grunwald DJ, Eisen JS. Headwaters of the zebrafish - emergence of a new model vertebrate. Nat Rev Genet 2002, 3:717-724.
46. Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD, Lewis RJ. Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 2005, 24:464-469. 10.1897/04-081R.1, 15720009.
47. Gaworecki KM, Klaine SJ. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquat Toxicol 2008, 88:207-213. 10.1016/j.aquatox.2008.04.011, 18547660.
48. Paterson G, Metcalfe CD. Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere 2008, 74:125-130. 10.1016/j.chemosphere.2008.08.022, 18845313.
49. Auer PL, Doerge RW. Statistical design and analysis of RNA sequencing data. Genetics 2010, 185:405-416. 10.1534/genetics.110.114983, 2881125, 20439781.
50. Wu TD, Nacu S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 2010, 26:873-881. 10.1093/bioinformatics/btq057, 2844994, 20147302.
51. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protocols 2012, 7:562-578.
52. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotech 2010, 28:511-515.
53. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotech 2013, 31:46-53.
54. Reimand J, Arak T, Vilo JG. Profiler-a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res 2011, 39:W307-W315. 10.1093/nar/gkr378, 3125778, 21646343.
55. Reimand J, Kull M, Peterson H, Hansen J, Vilo JG. Profiler-a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 2007, 35:W193-W200. 10.1093/nar/gkm226, 1933153, 17478515.
56. Cummings ME, Larkins-Ford J, Reilly CR, Wong RY, Ramsey M, Hofmann HA. Sexual and social stimuli elicit rapid and contrasting genomic responses. Proc Biol Sci 2008, 275:393-402. 10.1098/rspb.2007.1454, 2212751, 18055387.
57. Lynch KS, Ramsey ME, Cummings ME. The mate choice brain: comparing gene profiles between female choice and male coercive poeciliids. Genes Brain Behav 2012, 11:222-229. 10.1111/j.1601-183X.2011.00742.x, 22008245.
58. Ramsey ME, Maginnis TL, Wong RY, Brock C, Cummings ME. Identifying context-specific gene profiles of social, reproductive, and mate preference behavior in a fish species with female mate choice. Front Neurosci 2012, 6:62. 3340895, 22557945.
59. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30:e36. 10.1093/nar/30.9.e36, 113859, 11972351.
60. McCurley AT, Callard GV. Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC Mol Biol 2008, 9:102. 10.1186/1471-2199-9-102, 2588455, 19014500.
61. Sousa N, Almeida OF, Wotjak CT. A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes Brain Behav 2006, 5(Suppl 2):5-24.
62. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998, 95:3239-3244. 10.1073/pnas.95.6.3239, 19726, 9501247.
63. Godwin J, Thompson R. Nonapeptides and social behavior in fishes. Horm Behav 2012, 61:230-238. 10.1016/j.yhbeh.2011.12.016, 22285647.
64. Braida D, Donzelli A, Martucci R, Capurro V, Busnelli M, Chini B, Sala M. Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish. Psychopharmacology (Berl) 2012, 220:319-330.
65. Thorsell A. Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake. Ann N Y Acad Sci 2008, 1148:136-140. 10.1196/annals.1410.083, 19120101.
66. Neumann ID, Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci 2012, 35:649-659. 10.1016/j.tins.2012.08.004, 22974560.
67. Karlsson RM, Holmes A, Heilig M, Crawley JN. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav 2005, 80:427-436. 10.1016/j.pbb.2004.12.009, 15740785.
68. Slattery DA, Neumann ID. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61. 10.1016/j.neuropharm.2009.06.038, 19589349.
69. Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 2002, 26:259-283. 10.1016/S0149-7634(01)00066-5, 12034130.
70. Missig G, Ayers LW, Schulkin J, Rosen JB. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacology 2010, 35:2607-2616. 10.1038/npp.2010.155, 3055566, 20844476.
71. Trent NL, Menard JL. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat. Pharmacol Biochem Behav 2011, 99:580-590. 10.1016/j.pbb.2011.06.009, 21693128.
72. Onaka T, Takayanagi Y, Yoshida M. Roles of oxytocin neurones in the control of stress, energy metabolism, and social behaviour. J Neuroendocrinol 2012, 24:587-598. 10.1111/j.1365-2826.2012.02300.x, 22353547.
73. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 2011, 12:524-538. 10.1038/nrn3044, 21852800.
74. Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, Stout JC, Nathan PJ. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 2010, 35:2403-2413. 10.1038/npp.2010.123, 3055328, 20720535.
75. Petrovic P, Kalisch R, Singer T, Dolan RJ. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci 2008, 28:6607-6615. 10.1523/JNEUROSCI.4572-07.2008, 2647078, 18579733.
76. Donner J, Sipila T, Ripatti S, Kananen L, Chen X, Kendler KS, Lonnqvist J, Pirkola S, Hettema JM, Hovatta I. Support for involvement of glutamate decarboxylase 1 and neuropeptide Y in anxiety susceptibility. Am J Med Genet B Neuropsychiatr Genet 2012, 159B:316-327. 10.1002/ajmg.b.32029, 22328461.
77. Wendelaar Bonga SE. The stress response in fish. Physiol Rev 1997, 77:591-625.
78. Barton BA. Stress in fishes: a diversity of responses with particular reference to changes in circulating corticosteroids. Integr Comp Biol 2002, 42:517-525. 10.1093/icb/42.3.517, 21708747.
79. Alsop D, Vijayan MM. Molecular programming of the corticosteroid stress axis during zebrafish development. Comp Biochem Physiol A Mol Integr Physiol 2009, 153:49-54. 10.1016/j.cbpa.2008.12.008, 19146973.
80. Fekete EM, Zorrilla EP. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol 2007, 28:1-27. 10.1016/j.yfrne.2006.09.002, 2730896, 17083971.
81. Pan W, Kastin AJ. Urocortin and the brain. Prog Neurobiol 2008, 84:148-156. 10.1016/j.pneurobio.2007.10.008, 2267723, 18078706.
82. Gysling K, Forray MI, Haeger P, Daza C, Rojas R. Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?. Brain Res Brain Res Rev 2004, 47:116-125. 10.1016/j.brainresrev.2004.06.001, 15572167.
83. Neufeld-Cohen A, Tsoory MM, Evans AK, Getselter D, Gil S, Lowry CA, Vale WW, Chen A. A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proc Natl Acad Sci USA 2010, 107:19020-19025. 10.1073/pnas.1013761107, 2973872, 20937857.
84. Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Psychopharmacology (Berl) 2002, 160:113-121.
85. Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer SL, Shaw J, Fitz SD, Sajdyk TJ. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. Eur J Pharmacol 2005, 509:145-153. 10.1016/j.ejphar.2004.12.030, 15733549.
86. Moreau JL, Kilpatrick G, Jenck F. Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport 1997, 8:1697-1701. 10.1097/00001756-199705060-00027, 9189917.
87. Slawecki CJ, Somes C, Rivier JE, Ehlers CL. Neurophysiological effects of intracerebroventricular administration of urocortin. Peptides 1999, 20:211-218. 10.1016/S0196-9781(98)00160-0, 10422877.
88. Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 1999, 100:207-215. 10.1016/S0166-4328(98)00132-6, 10212068.
89. Venihaki M, Sakihara S, Subramanian S, Dikkes P, Weninger SC, Liapakis G, Graf T, Majzoub JA. Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J Neuroendocrinol 2004, 16:411-422. 10.1111/j.1365-2826.2004.01170.x, 15117334.
90. Jamieson PM, Li C, Kukura C, Vaughan J, Vale W. Urocortin 3 modulates the neuroendocrine stress response and is regulated in rat amygdala and hypothalamus by stress and glucocorticoids. Endocrinology 2006, 147:4578-4588. 10.1210/en.2006-0545, 16809443.
91. Deussing JM, Breu J, Kuhne C, Kallnik M, Bunck M, Glasl L, Yen YC, Schmidt MV, Zurmuhlen R, Vogl AM. Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J Neurosci 2010, 30:9103-9116.
92. Lennartsson AK, Jonsdottir IH. Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology 2011, 36:1530-1539. 10.1016/j.psyneuen.2011.04.007, 21621331.
93. Diaz-Moran S, Palencia M, Mont-Cardona C, Canete T, Blazquez G, Martinez-Membrives E, Lopez-Aumatell R, Tobena A, Fernandez-Teruel A. Coping style and stress hormone responses in genetically heterogeneous rats: comparison with the Roman rat strains. Behav Brain Res 2012, 228:203-210. 10.1016/j.bbr.2011.12.002, 22178313.
94. Torner L, Neumann ID. The brain prolactin system: involvement in stress response adaptations in lactation. Stress 2002, 5:249-257. 10.1080/1025389021000048638, 12475729.
95. Pottinger TG, Prunet P, Pickering AD. The effects of confinement stress on circulating prolactin levels in rainbow trout (Oncorhynchus mykiss) in fresh water. Gen Comp Endocrinol 1992, 88:454-460. 10.1016/0016-6480(92)90240-K, 1490590.
96. Avella M, Schreck CB, Prunet P. Plasma prolactin and cortisol concentrations of stressed coho salmon, Oncorhynchus kisutch, in fresh water or salt water. Gen Comp Endocrinol 1991, 81:21-27. 10.1016/0016-6480(91)90121-L, 2026313.
97. Liu GX, Cai GQ, Cai YQ, Sheng ZJ, Jiang J, Mei Z, Wang ZG, Guo L, Fei J. Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology 2007, 32:1531-1539. 10.1038/sj.npp.1301281, 17164814.
98. Mennigen JA, Martyniuk CJ, Crump K, Xiong H, Zhao E, Popesku J, Anisman H, Cossins AR, Xia X, Trudeau VL. Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). Physiol Genomics 2008, 35:273-282. 10.1152/physiolgenomics.90263.2008, 18765858.
99. Benton CS, Miller BH, Skwerer S, Suzuki O, Schultz LE, Cameron MD, Marron JS, Pletcher MT, Wiltshire T. Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology (Berl) 2012, 221:297-315.
100. Huang GJ, Ben-David E, Tort Piella A, Edwards A, Flint J, Shifman S. Neurogenomic evidence for a shared mechanism of the antidepressant effects of exercise and chronic fluoxetine in mice. PLoS One 2012, 7:e35901. 10.1371/journal.pone.0035901, 3338479, 22558262.
101. Lee JH, Ko E, Kim YE, Min JY, Liu J, Kim Y, Shin M, Hong M, Bae H. Gene expression profile analysis of genes in rat hippocampus from antidepressant treated rats using DNA microarray. BMC Neurosci 2010, 11:152. 10.1186/1471-2202-11-152, 3009642, 21118505.
102. Griffith M, Griffith OL, Mwenifumbo J, Goya R, Morrissy AS, Morin RD, Corbett R, Tang MJ, Hou YC, Pugh TJ. Alternative expression analysis by RNA sequencing. Nat Methods 2010, 7:843-847. 10.1038/nmeth.1503, 20835245.
103. Morey JS, Ryan JC, Van Dolah FM. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online 2006, 8:175-193. 10.1251/bpo126, 1779618, 17242735.
104. Hawlena D, Schmitz OJ. Herbivore physiological response to predation risk and implications for ecosystem nutrient dynamics. Proc Natl Acad Sci USA 2010, 107:15503-15507. 10.1073/pnas.1009300107, 2932623, 20713698.
105. Lima SL, Anders Pape Mã̧ller MM, Peter JBS. Stress and Decision Making under the Risk of Predation: Recent Developments from Behavioral, Reproductive, and Ecological Perspectives. Advances in the Study of Behavior. Volume, Volume 27 1998, 215-290. San Diego, CA USA: Academic Press Inc.
106. Santos EM, Kille P, Workman VL, Paull GC, Tyler CR. Sexually dimorphic gene expression in the brains of mature zebrafish. Comp Biochem Physiol A Mol Integr Physiol 2008, 149:314-324. 10.1016/j.cbpa.2008.01.010, 18289901.
107. Toth AL, Varala K, Newman TC, Miguez FE, Hutchison SK, Willoughby DA, Simons JF, Egholm M, Hunt JH, Hudson ME, Robinson GE. Wasp gene expression supports an evolutionary link between maternal behavior and eusociality. Science 2007, 318:441-444. 10.1126/science.1146647, 17901299.
108. Sen Sarma M, Whitfield CW, Robinson GE. Species differences in brain gene expression profiles associated with adult behavioral maturation in honey bees. BMC Genomics 2007, 8:202. 10.1186/1471-2164-8-202, 1929079, 17603883.
109. Whitfield CW, Cziko A-M, Robinson GE. Gene expression profiles in the brain predict behavior in individual honey bees. Science (Washington D C) 2003, 302:296-299.
110. Aubin-Horth N, Landry CR, Letcher BH, Hofmann HA. Alternative life histories shape brain gene expression profiles in males of the same population. Proc Biol Sci 2005, 272:1655-1662. 10.1098/rspb.2005.3125, 1559854, 16087419.
111. Renn SC, Aubin-Horth N, Hofmann HA. Fish and chips: functional genomics of social plasticity in an African cichlid fish. J Exp Biol 2008, 211:3041-3056. 10.1242/jeb.018242, 18775941.
112. Sanogo YO, Hankison S, Band M, Obregon A, Bell AM. Brain transcriptomic response of threespine sticklebacks to cues of a predator. Brain Behav Evol 2011, 77:270-285. 10.1159/000328221, 3182040, 21677424.
113. Catalan A, Hutter S, Parsch J. Population and sex differences in Drosophila melanogaster brain gene expression. BMC Genomics 2012, 13:654. 10.1186/1471-2164-13-654, 3527002, 23170910.
114. Drew RE, Settles ML, Churchill EJ, Williams SM, Balli S, Robison BD. Brain transcriptome variation among behaviorally distinct strains of zebrafish (Danio rerio). BMC Genomics 2012, 13:323. 10.1186/1471-2164-13-323, 3434030, 22817472.
115. Wong RY, Ramsey ME, Cummings ME. Localizing brain regions associated with female mate preference behavior in a swordtail. PLoS One 2012, 7:e50355. 10.1371/journal.pone.0050355, 3510203, 23209722.
116. Fitzpatrick MJ, Ben-Shahar Y, Smid HM, Vet LEM, Robinson GE, Sokolowski MB. Candidate genes for behavioural ecology. Trends Ecol Evol 2005, 20:96-104. 10.1016/j.tree.2004.11.017, 16701349.
117. Wada K, Howard JT, McConnell P, Whitney O, Lints T, Rivas MV, Horita H, Patterson MA, White SA, Scharff C. A molecular neuroethological approach for identifying and characterizing a cascade of behaviorally regulated genes. Proc Natl Acad Sci USA 2006, 103:15212-15217. 10.1073/pnas.0607098103, 1622802, 17018643.
118. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012, 40:D109-D114. 10.1093/nar/gkr988, 3245020, 22080510.
119. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30. 10.1093/nar/28.1.27, 102409, 10592173.
120. Mennigen JA, Lado WE, Zamora JM, Duarte-Guterman P, Langlois VS, Metcalfe CD, Chang JP, Moon TW, Trudeau VL. Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish, Carassius auratus. Aquat Toxicol 2010, 100:354-364. 10.1016/j.aquatox.2010.08.016, 20864192.
121. Gunn BG, Brown AR, Lambert JJ, Belelli D. Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress. Front Neurosci 2011, 5:131. 3230140, 22164129.
122. Zimmerberg B, Brunelli SA, Hofer MA. Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allopregnanolone. Pharmacol Biochem Behav 1994, 47:735-738. 10.1016/0091-3057(94)90181-3, 7911579.
123. Akwa Y, Purdy RH, Koob GF, Britton KT. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 1999, 106:119-125. 10.1016/S0166-4328(99)00101-1, 10595427.
124. Evans J, Sun Y, McGregor A, Connor B. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology 2012, 63:1315-1326. 10.1016/j.neuropharm.2012.08.012, 22939998.
125. Engin E, Treit D. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behav Pharmacol 2007, 18:461-470. 10.1097/FBP.0b013e3282d28f6f, 17762514.
126. Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot C, Schipper P, Korte-Bouws G, van Luijtelaar G, Reneman L. Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS One 2011, 6:e16646. 10.1371/journal.pone.0016646, 3031607, 21304948.
127. Bouet V, Klomp A, Freret T, Wylezinska-Arridge M, Lopez-Tremoleda J, Dauphin F, Boulouard M, Booij J, Gsell W, Reneman L. Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology (Berl) 2012, 221:329-339.
128. Olivier JD, Blom T, Arentsen T, Homberg JR. The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1400-1408. 10.1016/j.pnpbp.2010.09.013, 20883714.